The COVID-19 Diagnostics Market size is valued at USD 4.6 Bn in 2026.
The COVID-19 Diagnostics Market is projected to grow at a CAGR of 6% by 2033.
The COVID-19 Diagnostics Market growth is driven by rising infection rates, emergence of mutated variants, expanded testing programs, and regulatory support for screening.
North America is the dominating regional market for the COVID-19 Diagnostics Market.
Abbott Laboratories, Thermo Fisher Scientific Inc., Roche Diagnostics, Siemens Healthineers AG, and Danaher Corporation are some leading industry players in the COVID-19 Diagnostics Market.